Health ❯ Clinical Research

Drug Development

Clinical Trials Preclinical Studies Monoclonal Antibodies Regulatory Approval FDA Approval Phase 3 Trials Cancer Therapies Nektar Therapeutics Therapeutic Applications Therapeutics

LMU Team Creates Reproducible 3D Human Brain Spheroid That Models Alzheimer’s

Responding to anti‑Aβ antibodies in lab tests, the system could let drug makers test candidate therapies in human tissue at scale.

Argenx Agrees to Buy Forte Biosciences for $2.2 Billion

FDA Staff Flags Major Flaws in Capricor’s Deramiocel Data

Oral Antiviral Candidate Stops Measles-Like Virus Transmission in Ferret Study

McMaster Scientists Discover Manikomycin, a New Antibiotic Candidate

CVS Caremark Restores Zepbound and Adds Lilly’s Foundayo to Standard Formularies

Mexico Seeks Role as Latin America Clinical-Trial Hub With New Funding and AI

Immunovant Shares Surge on Strong Rheumatoid Arthritis Data for IMVT-1402

UNAM Scientists Turn Scorpion Venom and Habanero Chili Into Experimental Antibiotics

Oral GLP-1 Weight-Loss Pills Curb Hedonic Eating by Hitting Deep-Brain Circuit in Mice

Five-Target ‘Trojan Horse’ Drug Outperforms Leading Incretins in Obese Diabetic Mice

Clearmind’s AUD Candidate Meets Early Safety Goal as Shares Double

FDA Issues Second Rejection of Replimune’s RP1 Melanoma Therapy

Cholera-Derived Toxin Slows Colorectal Tumors in Mice, Rewiring Local Immunity

BioNTech Raises 2025 Sales Outlook After $1.5 Billion BMS Payment

FDA Approves Lynkuet, a Nonhormonal Pill for Menopausal Hot Flashes

FDA Signals Openness to Accelerated Path for Lexeo’s Friedreich’s Ataxia Cardiac Gene Therapy

Biomea Fusion Prices Equity Offering With Warrants to Raise About $25 Million

AI Pinpoints Target of New IBD Antibiotic Enterololin, Speeding Development

Eupraxia Selects 8 mg Dose After Strong EoE Signals, Expands Phase 2b Trial